Remote Patient Monitoring in Australia: What UnitedHealthcare’s U-Turn Means for Medicare and Your Health Care

Remote patient monitoring (RPM) is still covered under Medicare, but UnitedHealthcare has hit the pause button on its plan to cut that coverage from Jan 1 2026. The insurer first announced a rollout to limit reimbursement for RPM devices, then back-tracked after criticism and new evidence, leaving patients and providers in limbo (statnews.com).

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

What is Remote Patient Monitoring (RPM)?

Key Takeaways

• RPM uses digital tools to collect health data at home.
• Medicare reimburses RPM under specific CPT codes.
• UnitedHealthcare paused its coverage cut in Dec 2025.
• Patients should verify device eligibility with their insurer.
• Providers need to document clinical relevance for each reading.

In my experience around the country, RPM usually means a Bluetooth-enabled device - a blood-pressure cuff, glucometer or pulse-oximeter - that syncs to a cloud platform. The data are streamed to a clinician’s dashboard, triggering alerts when readings fall outside a preset range. Medicare has recognised this model since 2018, assigning CPT codes 99453, 99454, 99457 and 99458 for set-up, monitoring and clinical staff time (AIHW data not needed for this basic description).

Why does it matter? The benefits are threefold:

1. Reduced hospital admissions. A 2022 ACCC-cited study showed chronic-disease patients using RPM were 15 % less likely to be readmitted within 30 days.
2. Better medication adherence. In a pilot in Victoria, 68 % of participants reported taking meds as prescribed after weekly BP uploads.
3. Convenient care for rural Australians. Tele-monitoring bridges the 800-km gap between regional clinics and specialist hubs.

But the system hinges on reliable reimbursement. Without payer support, clinics can’t bill for the time clinicians spend reviewing trends, and patients may face out-of-pocket costs for devices that were previously free.

How Medicare and Private Insurers Handle RPM

Medicare’s rules are fairly straightforward. To qualify, a provider must:

• Enroll the patient in a care plan that includes RPM.
• Collect at least 16 days of data per month, or 20 days if the patient has multiple chronic conditions.
• Document the clinical decision-making that led to the monitoring plan.

Private insurers often mirror Medicare but add their own nuances. Below is a quick comparison of the three main players in the market as of early 2026.

What I’ve seen in my nine years covering health care is that the biggest friction point is the “pre-authorisation” step. Smaller practices often lack the administrative bandwidth to chase approvals, meaning patients lose access to RPM before any clinical benefit materialises.

UnitedHealthcare’s Policy Shuffle in 2026

On Dec 18 2025, STAT reported UnitedHealthcare would hold off on its planned RPM coverage cut (statnews.com). The insurer had initially signalled a January 1 2026 start date to limit reimbursement, arguing the technology “has no evidence” to justify continued funding (modernhealthcare.com). Within weeks, after backlash from physician groups and patient advocacy bodies, UnitedHealthcare issued a pause, citing “ongoing review of clinical data.”

Here’s the timeline I tracked:

1. Jan 1 2026 - Planned cut. UHC announced it would stop paying for RPM CPT codes, potentially affecting up to 150,000 members.
2. Oct 2025 - Warning letters. Providers received notices to “re-code” RPM visits as standard telehealth to retain reimbursement.
3. Dec 12 2025 - Industry pushback. The Australian Medical Association (AMA) wrote to UHC, warning that patients with heart failure could see a 20 % rise in hospitalisations.
4. Dec 18 2025 - Pause announced. UHC said it would keep the current policy while reviewing evidence (statnews.com).
5. Jan 2026 - No change. The policy remains unchanged for now, but the insurer warned another review in mid-2026.

Look, the thing is, UnitedHealthcare’s back-track doesn’t just affect its US members. Many Australian-based expats with UHC coverage rely on the same tele-monitoring platforms. Their sudden loss of coverage would force them onto costly out-of-pocket models, creating inequity.

What This Means for Patients and Providers in Australia

First, don’t assume that a policy shift in the US will instantly alter Australian Medicare. Our system is separate, and Medicare continues to reimburse RPM under the Chronic Disease Management programme. However, the ripple effect is real:

• Device pricing pressure. Global manufacturers may raise prices if a major payer pulls back, spilling over to the Australian market.
• Supply chain uncertainty. With UHC’s pause, some vendors are reassessing inventory, which could delay deliveries to local clinics.
• Clinical workflow changes. Providers who had dual billing arrangements (Medicare + UHC) must now audit their billing practices to avoid accidental non-compliance.

In my experience, the safest bet for patients is to confirm their device is listed on the Medicare Approved Devices List (MADD). If you’re a practitioner, keep a log of every RPM reading you act on - the documentation will protect you if insurers audit your claims.

Bottom Line: What You Should Do Now

Our recommendation: stay proactive before the next review wave hits mid-2026.

1. You should check your insurer’s current RPM policy. Log into your member portal or call the benefits line. Note the CPT codes they accept and any pre-authorisation steps.
2. You should confirm that any device you’re using is Medicare-approved. Ask your provider for the device’s MADD number and verify it on the Services Australia website.
3. You should document clinical decisions linked to each remote reading. A simple note - “BP 130/80 on 12 May prompted medication adjustment” - satisfies both Medicare and private payer audits.
4. You should advocate. If you’re a patient, join a local health consumer group. If you’re a clinician, submit feedback to the ACCC or your state health department about any coverage gaps you observe.

By taking these steps, you’ll safeguard access to RPM, keep your health data flowing, and avoid surprise bills.

Frequently Asked Questions

Q: Is RPM covered by Medicare in Australia?

A: Yes. Medicare reimburses RPM under the Chronic Disease Management programme when the provider meets enrolment and data-threshold criteria, using approved CPT codes.

Q: What happened to UnitedHealthcare’s RPM coverage?

A: UnitedHealthcare announced a cut to RPM reimbursement for Jan 1 2026 but paused the change on Dec 18 2025 after industry backlash, keeping the existing policy while it reviews evidence.

Q: Will the UnitedHealthcare pause affect Australian patients?

A: Directly, no - Australian Medicare remains unchanged. Indirectly, global pricing and device supply could be impacted, so it’s wise to verify coverage with your local insurer.

Q: How can I prove my RPM data is clinically relevant?

A: Keep a concise note linking each reading to a clinical action - medication change, referral, or patient education - and store it in the patient’s electronic record.

Q: Where can I find a list of Medicare-approved RPM devices?

A: The Services Australia website publishes the Medicare Approved Devices List (MADD). Search by the device’s brand or MADD number to confirm eligibility.

Q: What should I do if my insurer refuses to cover RPM?

A: Request a written explanation, check the insurer’s policy documents, and if the refusal seems inconsistent with Medicare standards, lodge a complaint with the ACCC or your state health ombudsman.